Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

Journal of Experimental Medicine

Volumn 211, Issue 12, 2014, Pages 2467-2479

  Yang, Heeyoung ^a   Qiu, Quan ^a   Gao, Beixue ^a   Kong, Sinyi ^a   Lin, Zhenghong ^a   Fang, Deyu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B7 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN HRD1; TOLL LIKE RECEPTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2; HRD1 PROTEIN, MOUSE; PRDM1 PROTEIN, MOUSE; PROTEIN BINDING; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOBLOTTING; INFLAMMATION; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84911924274     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20140283     Document Type: Article

References (57)

1. Adams, E.J., and A.M. Luoma. 2013. The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Annu. Rev. Immunol. 31:529-561. http://dx.doi.org/10.1146/annurev-immunol-032712-095912
2. Amano, T., S. Yamasaki, N. Yagishita, K. Tsuchimochi, H. Shin, K. Kawahara, S. Aratani, H. Fujita, L. Zhang, R. Ikeda, et al. 2003. Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17:2436-2449. http://dx.doi.org/10.1101/gad.1096603
3. Burr, M.L., F. Cano, S. Svobodova, L.H. Boyle, J.M. Boname, and P.J. Lehner. 2011. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc. Natl. Acad. Sci. USA. 108:2034-2039. http://dx.doi.org/10.1073/pnas.1016229108
4. Carvalho, P., V. Goder, and T.A. Rapoport. 2006. Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell. 126:361-373. http://dx.doi.org/10.1016/j.cell.2006.05.043
5. Casals, C., M. Barrachina, M. Serra, J. Lloberas, and A. Celada. 2007. Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA. J. Immunol. 178:6307-6315. http://dx.doi.org/10.4049/jimmunol.178.10.6307
6. Chang, C.H., J.D. Fontes, M. Peterlin, and R.A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374. http://dx.doi.org/10.1084/jem.180.4.1367
7. Chang, D.H., C. Angelin-Duclos, and K. Calame. 2000. BLIMP-1: trigger for differentiation of myeloid lineage. Nat. Immunol. 1:169-176. http://dx.doi.org/10.1038/77861
8. Chen, H., C.A. Gilbert, J.A. Hudson, S.C. Bolick, K.L. Wright, and J.F. Piskurich. 2007. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter. Mol. Immunol. 44:1461-1470. http://dx.doi.org/10.1016/j.molimm.2006.04.026
9. Collins, T., A.J. Korman, C.T. Wake, J.M. Boss, D.J. Kappes, W. Fiers, K.A. Ault, M.A. Gimbrone Jr., J.L. Strominger, and J.S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA. 81:4917-4921. http://dx.doi.org/10.1073/pnas.81.15.4917
10. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621-663. http://dx.doi.org/10.1146/annurev-immunol-031210-101400
11. De Gassart, A., V. Camosseto, J. Thibodeau, M. Ceppi, N. Catalan, P. Pierre, and E. Gatti. 2008. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I downregulation. Proc. Natl. Acad. Sci. USA. 105:3491-3496. http://dx.doi.org/10.1073/pnas.0708874105
12. Denic, V., E.M. Quan, and J.S. Weissman. 2006. A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation. Cell. 126:349-359. http://dx.doi.org/10.1016/j.cell.2006.05.045
13. Drozina, G., J. Kohoutek, N. Jabrane-Ferrat, and B.M. Peterlin. 2005. Expression of MHC II genes. Curr. Top. Microbiol. Immunol. 290:147-170.
14. Friese, M.A., E.Y. Jones, and L. Fugger. 2005. MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol. 26:559-561. http://dx.doi.org/10.1016/j.it.2005.08.011
15. Gao, B., K. Calhoun, and D. Fang. 2006. The proinflammatory cytokines IL-1β and TNF-α induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway. Arthritis Res. Ther. 8:R172. http://dx.doi.org/10.1186/ar2081
16. Gao, B., S.M. Lee, A. Chen, J. Zhang, D.D. Zhang, K. Kannan, R.A. Ortmann, and D. Fang. 2008. Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis. EMBO Rep. 9:480-485. http://dx.doi.org/10.1038/embor.2008.37
17. Greer, S.F., E. Zika, B. Conti, X.S. Zhu, and J.P. Ting. 2003. Enhancement of CIITA transcriptional function by ubiquitin. Nat. Immunol. 4:1074-1082. http://dx.doi.org/10.1038/ni985
18. Huang, L., J.M. Marvin, N. Tatsis, and L.C. Eisenlohr. 2011. Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation. J. Immunol. 186:1904-1908. http://dx.doi.org/10.4049/jimmunol.1003411
19. Ishido, S., E. Goto, Y. Matsuki, and M. Ohmura-Hoshino. 2009. E3 ubiquitin ligases for MHC molecules. Curr. Opin. Immunol. 21:78-83. http://dx.doi.org/10.1016/j.coi.2009.01.002
20. Iwakoshi, N.N., M. Pypaert, and L.H. Glimcher. 2007. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J. Exp. Med. 204:2267-2275. http://dx.doi.org/10.1084/jem.20070525
21. Kikuchi, Y., T. Yasue, K. Miyake, M. Kimoto, and K. Takatsu. 1995. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor α chain: synergistic effects with interleukin 5. Proc. Natl. Acad. Sci. USA. 92:11814-11818. http://dx.doi.org/10.1073/pnas.92.25.11814
22. Kim, S.J., P.K. Gregersen, and B. Diamond. 2013. Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J. Clin. Invest. 123:823-833.
23. Koeffler, H.P., J. Ranyard, L. Yelton, R. Billing, and R. Bohman. 1984. γ-interferon induces expression of the HLA-D antigens on normal and leukemic human myeloid cells. Proc. Natl. Acad. Sci. USA. 81:4080-4084. http://dx.doi.org/10.1073/pnas.81.13.4080
24. Landmann, S., A. Mühlethaler-Mottet, L. Bernasconi, T. Suter, J.M. Waldburger, K. Masternak, J.F. Arrighi, C. Hauser, A. Fontana, and W. Reith. 2001. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J. Exp. Med. 194:379-392. http://dx.doi.org/10.1084/jem.194.4.379
25. Lee, S.M., B. Gao, and D. Fang. 2008. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood. 111:3599-3606. http://dx.doi.org/10.1182/blood-2007-09-115014
26. Lee, S.M., B. Gao, M. Dahl, K. Calhoun, and D. Fang. 2009. Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis. Otolaryngol. Head Neck Surg. 140:197-201. http://dx.doi.org/10.1016/j.otohns.2008.08.016
27. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA. 96:10338-10343. http://dx.doi.org/10.1073/pnas.96.18.10338
28. Mansour, M.K., E. Latz, and S.M. Levitz. 2006. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176:3053-3061. http://dx.doi.org/10.4049/jimmunol.176.5.3053
29. Martins, G., and K. Calame. 2008. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26:133-169. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090241
30. Maseda, D., S.H. Smith, D.J. DiLillo, J.M. Bryant, K.M. Candando, C.T. Weaver, and T.F. Tedder. 2012. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 188:1036-1048. http://dx.doi.org/10.4049/jimmunol.1102500
31. Matsuki, Y., M. Ohmura-Hoshino, E. Goto, M. Aoki, M. Mito-Yoshida, M. Uematsu, T. Hasegawa, H. Koseki, O. Ohara, M. Nakayama, et al. 2007. Novel regulation of MHC class II function in B cells. EMBO J. 26:846-854. http://dx.doi.org/10.1038/sj.emboj.7601556
32. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31:563-604. http://dx.doi.org/10.1146/annurev-immunol-020711-074950
33. Miller, J.C., B.D. Brown, T. Shay, E.L. Gautier, V. Jojic, A. Cohain, G. Pandey, M. Leboeuf, K.G. Elpek, J. Helft, et al. Immunological Genome Consortium. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13:888-899. http://dx.doi.org/10.1038/ni.2370
34. Moffat, J.M., J.D. Mintern, and J.A. Villadangos. 2013. Control of MHC II antigen presentation by ubiquitination. Curr. Opin. Immunol. 25:109-114. http://dx.doi.org/10.1016/j.coi.2012.10.008
35. Pai, R.K., D. Askew, W.H. Boom, and C.V. Harding. 2002. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. J. Immunol. 169:1326-1333. http://dx.doi.org/10.4049/jimmunol.169.3.1326
36. Pierson, E., S.B. Simmons, L. Castelli, and J.M. Goverman. 2012. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248:205-215. http://dx.doi.org/10.1111/j.1600-065X.2012.01126.x
37. Piskurich, J.F., K.I. Lin, Y. Lin, Y. Wang, J.P. Ting, and K. Calame. 2000. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:526-532. http://dx.doi.org/10.1038/82788
38. Qiu, Q., Z. Zheng, L. Chang, Y.S. Zhao, C. Tan, A. Dandekar, Z. Zhang, Z. Lin, M. Gui, X. Li, et al. 2013. Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis. EMBO J. 32:2477-2490. http://dx.doi.org/10.1038/emboj.2013.183
39. Reis e Sousa, C. 2004. Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16:21-25. http://dx.doi.org/10.1016/j.coi.2003.11.007
40. Rudolph, M.G., R.L. Stanfield, and I.A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24:419-466. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115658
41. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352. http://dx.doi.org/10.1038/ni1178
42. Shen, X., R.E. Ellis, K. Lee, C.Y. Liu, K. Yang, A. Solomon, H. Yoshida, R. Morimoto, D.M. Kurnit, K. Mori, and R.J. Kaufman. 2001. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell. 107:893-903. http://dx.doi.org/10.1016/S0092-8674(01)00612-2
43. Simard, N., D. Konforte, A.H. Tran, J. Esufali, W.J. Leonard, and C.J. Paige. 2011. Analysis of the role of IL-21 in development of murine B cell progenitors in the bone marrow. J. Immunol. 186:5244-5253. http://dx.doi.org/10.4049/jimmunol.1004040
44. Steffen, J., M. Seeger, A. Koch, and E. Krüger. 2010. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell. 40:147-158. http://dx.doi.org/10.1016/j.molcel.2010.09.012
45. Steimle, V., L.A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:135-146. http://dx.doi.org/10.1016/0092-8674(93)90685-J
46. Tooze, R.M., S. Stephenson, and G.M. Doody. 2006. Repression of IFN-γ induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling. J. Immunol. 177:4584-4593. http://dx.doi.org/10.4049/jimmunol.177.7.4584
47. Tsuchiya, Y., T. Morita, M. Kim, S. Iemura, T. Natsume, M. Yamamoto, and A. Kobayashi. 2011. Dual regulation of the transcriptional activity of Nrf1 by β-TrCP- and Hrd1-dependent degradation mechanisms. Mol. Cell. Biol. 31:4500-4512. http://dx.doi.org/10.1128/MCB.05663-11
48. Tze, L.E., K. Horikawa, H. Domaschenz, D.R. Howard, C.M. Roots, R.J. Rigby, D.A. Way, M. Ohmura-Hoshino, S. Ishido, C.E. Andoniou, et al. 2011. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208:149-165. http://dx.doi.org/10.1084/jem.20092203
49. Walseng, E., K. Furuta, B. Bosch, K.A. Weih, Y. Matsuki, O. Bakke, S. Ishido, and P.A. Roche. 2010. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. USA. 107:20465-20470. http://dx.doi.org/10.1073/pnas.1010990107
50. Wu, T., F. Zhao, B. Gao, C. Tan, N. Yagishita, T. Nakajima, P.K. Wong, E. Chapman, D. Fang, and D.D. Zhang. 2014. Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev. 28:708-722. http://dx.doi.org/10.1101/gad.238246.114
51. Yamasaki, S., N. Yagishita, T. Sasaki, M. Nakazawa, Y. Kato, T. Yamadera, E. Bae, S. Toriyama, R. Ikeda, L. Zhang, et al. 2007. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 26:113-122. http://dx.doi.org/10.1038/sj.emboj.7601490
52. Yang, H., S.M. Lee, B. Gao, J. Zhang, and D. Fang. 2013. Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation. J. Biol. Chem. 288:37256-37266. http://dx.doi.org/10.1074/jbc.M113.527531
53. Yao, Y., Q. Xu, M.J. Kwon, R. Matta, Y. Liu, S.C. Hong, and C.H. Chang. 2006. ERK and p38 MAPK signaling pathways negatively regulate CIITA gene expression in dendritic cells and macrophages. J. Immunol. 177:70-76. http://dx.doi.org/10.4049/jimmunol.177.1.70
54. Young, L.J., N.S. Wilson, P. Schnorrer, A. Proietto, T. ten Broeke, Y. Matsuki, A.M. Mount, G.T. Belz, M. O'Keeffe, M. Ohmura-Hoshino, et al. 2008. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9:1244-1252. http://dx.doi.org/10.1038/ni.1665
55. Zhang, J., S.M. Lee, S. Shannon, B. Gao, W. Chen, A. Chen, R. Divekar, M.W. McBurney, H. Braley-Mullen, H. Zaghouani, and D. Fang. 2009. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J. Clin. Invest. 119:3048-3058. http://dx.doi.org/10.1172/JCI38902
56. Zhang, K., S. Wang, J. Malhotra, J.R. Hassler, S.H. Back, G. Wang, L. Chang, W. Xu, H. Miao, R. Leonardi, et al. 2011. The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis. EMBO J. 30:1357-1375. http://dx.doi.org/10.1038/emboj.2011.52
57. Zhao, M., F.L. Flynt, M. Hong, H. Chen, C.A. Gilbert, N.T. Briley, S.C. Bolick, K.L. Wright, and J.F. Piskurich. 2007. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-γ. Mol. Immunol. 44:2923-2932. http://dx.doi.org/10.1016/j.molimm.2007.01.009